The FDA approved Neupro (Rotigotine Transdermal System) for the treatment of Parkinson's disease and restless leg syndrome.
Jocelyn Thomas, PharmD
Advertisement
Articles by Jocelyn Thomas, PharmD
Advertisement
Latest Updated Articles
- Forest Laboratories' Viibryd
Published: August 10th 2011 | Updated:
- New FDA Actions: UCB's Neupro
Published: July 10th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
2
Data Suggest Routine Multicancer Early Detection Tests Could Reduce Late–Stage Diagnoses
3
Measles On the Rise: Global Surge and US Status at Risk
4
November 2025 Trending Products
5
